Please use this identifier to cite or link to this item: http://hdl.handle.net/10773/37402
Title: Multicomponent and 1,3-dipolar cycloaddition synthesis of triazole- and isoxazole-acridinedione/xanthenedione heterocyclic hybrids: cytotoxic effects on human cancer cells
Author: Naouri, Abdelkader
Djemoui, Amar
Ouahrani, Mouhamad Ridha
Lahrech, Mokhtar Boualem
Lemouari, Najet
Rocha, Djenisa H.A.
Albuquerque, Hélio
Mendes, Ricardo F.
Almeida Paz, Filipe A.
Helguero, Luisa A.
Bachari, Khaldoun
Talhi, Oualid
Silva, Artur M.S.
Keywords: Click chemistry
Triazole
Isoxazole
Acridinedione
Xanthenedione
Anticancer
Issue Date: 5-Oct-2020
Publisher: Elsevier
Abstract: A new series of diverse 1,2,3-triazole-acridinedione/xanthenedione and 1,2-isoxazole-acridinedione/xanthenedione heterocyclic hybrids have been synthesized via 1,3-dipolar coupling reaction of N/O-substituted-acridinedione-alkyne or O-substituted-xanthenedione-alkyne substrates with various aromatic azides or oximes. In all cases, the cycloaddition is totally regioselective. The chemical structures of the synthesized compounds are determined using 2D NMR and are further confirmed by single-crystal X-ray diffraction analysis. Preliminary in vitro cytotoxic assays on two human breast cancer cell lines (MDA-MB-231, T47-D) and one prostate cancer cell line (PC3) are performed on some selected compounds. The most active O-1,2,3-triazole-xanthenedione hybrid displays the best cytotoxicity effects with IC50 ≤ 20 μM in breast cancer and IC50 = 10 μM in prostate cancer cell lines.
Peer review: yes
URI: http://hdl.handle.net/10773/37402
DOI: 10.1016/j.molstruc.2020.128325
ISSN: 0022-2860
Appears in Collections:CICECO - Artigos
IBIMED - Artigos
DQ - Artigos
QOPNA - Artigos
DCM - Artigos
REQUIMTE - Artigos

Files in This Item:
File Description SizeFormat 
Multicomponent and 1,3-dipolar cycloaddition synthesis of triazole.pdf1.85 MBAdobe PDFView/Open


FacebookTwitterLinkedIn
Formato BibTex MendeleyEndnote Degois 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.